A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine - Concepedia

Concepedia

Publication | Closed Access

A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine

97

Citations

17

References

2007

Year

P Thongcharoen, Vinai Suriyanon, Robert Paris, Chirasak Khamboonruang, Mark de Souza, Silvia Ratto‐Kim, Chitraporn Karnasuta, Victoria R. Polonis, Lynn Baglyos, Raphaëlle El Habib,

JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

These 2 different prime-boost regimens seem to be safe and displayed cell-mediated immune responses consistent with those in other trials of canarypox vectors.

References

	Year	Citations

Page 1